InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,290.86
(
2.02%
)
US TECH 100
17,844.40
(
2.47%
)
Dow Jones
39,253.27
(
1.42%
)
Brent Oil
76.87
(
-0.38%
)
Bitcoin
56,824.54
(
5.24%
)
Post# of 64738
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Paulness

Send PM Follow Ignore
Followers 94
Posts 11260
Boards Moderated 0
Alias Born 11/02/2003

Paulness

Re: Paulness post# 22441

Sunday, 08/21/2005 10:19:50 PM

Sunday, August 21, 2005 10:19:50 PM

Post# of 64738
I really like this part.

Dr. Malcolm Skolnick, CytoGenix President and CEO commented, "This is the next step in our march to make pharmaceutical grade DNA affordable. This is truly a breakthrough technology that changes the economics of cost-sensitive products such as DNA vaccines, antimicrobials and cancer immunotherapy. In the next few years, this technology will drive the development of DNA therapeutics for human and animal application by significantly reducing the costs of finished products
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up